Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer

Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer

Background Epstein-Barr virus (EBV)-associated gastric cancer (GC) (EBVaGC) is a distinct molecular subtype of GC with a favorable prognosis. However, the exact effects and potential mechanisms of EBV infection on immune checkpoint blockade (ICB) efficacy in GC remain to be clarified. Additionally,...

Full description

Bibliographic Details
Main Authors: Lin Shen, Xiaochen Zhao, Zhenghang Wang, Yuezong Bai, Feilong Zhao, Zhi Peng, Jinping Cai, Tong Xie, Shuang Tong, Xiaofan Wei
Format: Article
Language:English
Published: BMJ Publishing Group 2022-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/3/e004080.full

Internet

https://jitc.bmj.com/content/10/3/e004080.full

Similar Items